Anthony Ford-Hutchinson
Directeur Technique/Scientifique/R&D chez RiboNova, Inc.
Profil
Anthony W.
Ford-Hutchinson is currently the Director & Chief Scientific Officer at RiboNova, Inc. and also holds the position of Director at Sage Bionetworks.
Previously, he worked as a Director at Novira Therapeutics LLC, BioLeap, Inc., and Context Therapeutics LLC.
He also worked as a Principal at Merck Frosst Canada Ltd.
Dr. Ford-Hutchinson holds a doctorate degree from the University of London, an undergraduate degree from the University of Birmingham, and a graduate degree from the University of Warwick.
Postes actifs de Anthony Ford-Hutchinson
| Sociétés | Poste | Début |
|---|---|---|
Sage Bionetworks
 Sage Bionetworks Miscellaneous Commercial ServicesCommercial Services Sage Bionetworks is a non-profit organization based in Seattle, WA that was founded in 2009 by Stephen H. Friend. The private company focuses on developing and applying open practices to data-driven research for the advancement of human health. The company's interdisciplinary team of scientists and engineers work together to provide researchers access to technology tools and scientific approaches to share data, benchmark methods, and explore collective insights, all backed by Sage's gold-standard governance protocols and commitment to user-centered design. Sage is a 501c3 and is supported through a portfolio of competitive research grants, commercial partnerships, and philanthropic contributions. | Directeur/Membre du Conseil | - |
RiboNova, Inc.
 RiboNova, Inc. Pharmaceuticals: MajorHealth Technology RiboNova, Inc. manufactures molecule drugs. The firm provides biomedical research services. The company was founded by David P. Hesson and is headquartered in Wynnewood, PA. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Anthony Ford-Hutchinson
| Sociétés | Poste | Fin |
|---|---|---|
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | - |
BioLeap, Inc.
 BioLeap, Inc. Pharmaceuticals: MajorHealth Technology BioLeap, Inc. discovers, designs and develops drug pharmaceutical products. Its process creates novel compounds with intellectual property protection, enhances the intellectual property estate around existing compounds, avoids obstructive patents and generates fast-follower compounds. The company was founded by Gerald H. Evans and John L. Kulp in 2004 and is headquartered in Pennington, NJ. | Directeur/Membre du Conseil | - |
Merck Frosst Canada Ltd.
 Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Merck Frosst Canada Ltd. is a Canadian pharmaceutical company that has been inventing medicines and vaccines for over 130 years. The company is based in Kirkland, Canada. The company's mission is to save and improve lives by bringing forward solutions for some of the world's most challenging diseases. | Corporate Officer/Principal | - |
Novira Therapeutics LLC
 Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Directeur/Membre du Conseil | - |
Formation de Anthony Ford-Hutchinson
| University of London | Doctorate Degree |
| University of Birmingham | Undergraduate Degree |
| University of Warwick | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Merck Frosst Canada Ltd.
Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Merck Frosst Canada Ltd. is a Canadian pharmaceutical company that has been inventing medicines and vaccines for over 130 years. The company is based in Kirkland, Canada. The company's mission is to save and improve lives by bringing forward solutions for some of the world's most challenging diseases. | Health Technology |
BioLeap, Inc.
BioLeap, Inc. Pharmaceuticals: MajorHealth Technology BioLeap, Inc. discovers, designs and develops drug pharmaceutical products. Its process creates novel compounds with intellectual property protection, enhances the intellectual property estate around existing compounds, avoids obstructive patents and generates fast-follower compounds. The company was founded by Gerald H. Evans and John L. Kulp in 2004 and is headquartered in Pennington, NJ. | Health Technology |
RiboNova, Inc.
RiboNova, Inc. Pharmaceuticals: MajorHealth Technology RiboNova, Inc. manufactures molecule drugs. The firm provides biomedical research services. The company was founded by David P. Hesson and is headquartered in Wynnewood, PA. | Health Technology |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
Sage Bionetworks
Sage Bionetworks Miscellaneous Commercial ServicesCommercial Services Sage Bionetworks is a non-profit organization based in Seattle, WA that was founded in 2009 by Stephen H. Friend. The private company focuses on developing and applying open practices to data-driven research for the advancement of human health. The company's interdisciplinary team of scientists and engineers work together to provide researchers access to technology tools and scientific approaches to share data, benchmark methods, and explore collective insights, all backed by Sage's gold-standard governance protocols and commitment to user-centered design. Sage is a 501c3 and is supported through a portfolio of competitive research grants, commercial partnerships, and philanthropic contributions. | Commercial Services |
Novira Therapeutics LLC
Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Health Technology |